Latest Commercial Contracts News

Eden Innovations’ US subsidiary has secured its first EdenCrete®Pz7 order from Holcim Mexico, marking the product’s expansion to three countries within the Holcim Group’s concrete operations.

4DMedical has landed a significant commercial contract with Intermountain Health to deploy its FDA-cleared Pulmonary Hypertension Analysis (PHA™) product, marking a key milestone in its U.S. expansion through a strategic Microsoft-backed partnership.

Zimi Limited confirms $1.42 million in open orders with key distributor GSM Electrical, backed by shareholder approval for up to $6 million in future sales. The company also advances its commercial market ambitions through a new partnership with Zencontrol.

Genetic Signatures Ltd reported a robust 71% jump in quarterly sales to $2.9 million, fueled by strong respiratory testing demand in Australia and key US commercial contracts. The company is advancing its automation and instrument customisation strategy to streamline molecular diagnostics offerings.

Carnegie Clean Energy has advanced its ACHIEVE Programme with a key contract for CETO deployment at the Basque Marine Energy Platform, securing milestone payments exceeding €1.5 million and launching a new Investor Hub to enhance shareholder engagement.

Gratifii Limited reported a record quarterly cash receipt surge of 111% year-on-year, driven by key contract wins and successful platform migration despite cyclone disruptions. The company advances its post-merger integration and eyes an $84m revenue run rate in FY26.

Novatti Group Limited has achieved a key turnaround milestone by reporting positive cash EBITDA of $100k in Q3 FY25, alongside record quarterly revenue of $13.4 million and improved margins in its core Payments AU/NZ business.

4DMedical Limited reports a 103% surge in year-to-date revenue, secures major contracts with leading healthcare providers, and advances its CT:VQ™ technology towards FDA clearance.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Artrya has secured a pivotal three-year commercial contract with Sonic Healthcare Australia to deploy its AI-driven Salix Coronary Anatomy platform across over 125 radiology centres, marking a significant step in commercialising its coronary artery disease diagnostic technology.

Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.